ArticleInvestigative and clinical urology2019

CRTC2 as a novel prognostic biomarker for worse pathologic outcomes and biochemical recurrence after radical prostatectomy in patients with prostate cancer.

Hakmin Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.